Watchlist Price Alert

Viking Therapeutics Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

26.95

0.87 (3.34%)

At close: Jun 16, 2025, 3:59 PM

26.79

-0.58%

Pre-market: Jun 17, 2025, 05:40 AM EDT

Viking Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	292K	291K	296K	277K	260K	n/a	n/a	n/a
Gross Profit	n/a	-292K	-291K	-296K	-277K	-260K	n/a	n/a	n/a
Operating Income	-150.92M	-100.83M	-70.36M	-55.68M	-42.66M	-32.69M	-26.16M	-19.07M	-13.85M
Interest Income	n/a	15.02M	1.59M	703K	3.23M	7.05M	3.24M	1.27K	n/a
Pretax Income	-109.96M	-85.89M	-68.87M	-54.99M	-39.49M	-25.78M	-22.06M	-20.58M	-14.73M
Net Income	-109.96M	-85.89M	-67.38M	-54M	-36.05M	-25.78M	-22.06M	-20.58M	-14.73M
Selling & General & Admin	49.28M	37.02M	16.12M	10.7M	10.73M	9.13M	7.12M	5.33M	4.85M
Research & Development	101.64M	63.81M	54.23M	44.98M	31.93M	23.56M	19.04M	13.74M	9M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	1.4M	344.93K	1.06M
Operating Expenses	150.92M	100.83M	70.36M	55.68M	42.66M	32.69M	26.16M	19.07M	13.85M
Interest Expense	n/a	88K	n/a	18K	106K	146K	404K	1.28M	1.81M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	100.83M	70.36M	55.68M	42.66M	32.69M	26.16M	19.07M	13.85M
Income Tax Expense	n/a	n/a	-1.49M	-988K	-3.44M	6.99M	-2.71M	1.85M	1.95M
Shares Outstanding (Basic)	109.04M	94.35M	76.83M	77.2M	72.6M	71.96M	57.58M	25.98M	16.28M
Shares Outstanding (Diluted)	109.04M	94.35M	76.83M	77.2M	72.6M	71.96M	57.58M	25.98M	16.28M
EPS (Basic)	-1.01	-0.91	-0.88	-0.7	-0.5	-0.36	-0.38	-0.79	-0.9
EPS (Diluted)	-1.01	-0.91	-0.88	-0.7	-0.5	-0.36	-0.38	-0.79	-0.9
EBITDA	-109.52M	-100.83M	-70.36M	-55.39M	-42.66M	-25.37M	4.66M	442.88K	1.15M
EBIT	n/a	-100.83M	-70.36M	-55.68M	-42.66M	-25.63M	-21.5M	-18.63M	-12.7M
Depreciation & Amortization	n/a	292K	291K	296K	277K	260K	26.16M	19.07M	13.85M